Detalles de la búsqueda
1.
Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 541-553, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-925673
2.
Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 199-206, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874343
3.
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 945-956, 2020.
Artículo
| WPRIM | ID: wpr-831097
4.
Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 149-166, 2020.
Artículo
| WPRIM | ID: wpr-831079
5.
Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 886-900, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763190
6.
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 1167-1179, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763163
7.
Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 832-840, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763113
Resultados
1 -
7
de 7
1
Próxima >
>>